Marshall Wace North America’s Kite Pharma, Inc. KITE Stock Holding History

Marshall Wace North America’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-62,618	Closed	-$11.3M	–	1801
2017 Q3	$11.3M	Buy	+62,618	New	+$8.73M	0.07%	338

Marshall Wace North America's KITE Position: Q4 2017 in Review

Marshall Wace North America sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 62,618 shares — an estimated $11.3M sold.

Marshall Wace North America first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $11.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Marshall Wace North America reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Marshall Wace North America sold 62,618 Kite Pharma, Inc. shares in Q4 2017, an estimated $11.3M.
Marshall Wace North America first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Marshall Wace North America's Kite Pharma, Inc. position peaked at $11.3M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.